121 related articles for article (PubMed ID: 2328552)
1. Effects of age on the protein binding and disposition of propranolol stereoisomers.
Lalonde RL; Tenero DM; Burlew BS; Herring VL; Bottorff MB
Clin Pharmacol Ther; 1990 Apr; 47(4):447-55. PubMed ID: 2328552
[TBL] [Abstract][Full Text] [Related]
2. Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomers.
Hunt BA; Bottorff MB; Herring VL; Self TH; Lalonde RL
Clin Pharmacol Ther; 1990 May; 47(5):584-91. PubMed ID: 2344707
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective binding of propranolol to human plasma, alpha 1-acid glycoprotein, and albumin.
Walle UK; Walle T; Bai SA; Olanoff LS
Clin Pharmacol Ther; 1983 Dec; 34(6):718-23. PubMed ID: 6641085
[TBL] [Abstract][Full Text] [Related]
4. Age and propranolol stereoselective disposition in humans.
Colangelo PM; Blouin RA; Steinmetz JE; McNamara PJ; DeMaria AN; Wedlund PJ
Clin Pharmacol Ther; 1992 May; 51(5):489-94. PubMed ID: 1587061
[TBL] [Abstract][Full Text] [Related]
5. Age and gender influence the stereoselective pharmacokinetics of propranolol.
Gilmore DA; Gal J; Gerber JG; Nies AS
J Pharmacol Exp Ther; 1992 Jun; 261(3):1181-6. PubMed ID: 1602383
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective clearance and distribution of intravenous propranolol.
Olanoff LS; Walle T; Walle UK; Cowart TD; Gaffney TE
Clin Pharmacol Ther; 1984 Jun; 35(6):755-61. PubMed ID: 6734027
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of ageing on the stereochemical disposition of propranolol.
Zhou HH; Whelan E; Wood AJ
Br J Clin Pharmacol; 1992 Jan; 33(1):121-3. PubMed ID: 1540484
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
Marier JF; Pichette V; du Souich P
Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
[TBL] [Abstract][Full Text] [Related]
9. Contribution of differences in plasma binding of propranolol to ethnic differences in sensitivity. Comparison between Chinese and Caucasians.
Zhou HH; Shay SD; Wood AJ
Chin Med J (Engl); 1993 Dec; 106(12):898-902. PubMed ID: 8143506
[TBL] [Abstract][Full Text] [Related]
10. Nonlinear pharmacokinetics of unbound propranolol after oral administration.
Straka RJ; Lalonde RL; Pieper JA; Bottorff MB; Mirvis DM
J Pharm Sci; 1987 Jul; 76(7):521-4. PubMed ID: 3668812
[TBL] [Abstract][Full Text] [Related]
11. Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat.
Laethem ME; Belpaire FM; Wijnant P; Rosseel MT; Bogaert MG
Chirality; 1994; 6(5):405-10. PubMed ID: 8068500
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective binding of propranolol in the elderly.
Colangelo P; Chandler M; Blouin R; McNamara P
Br J Clin Pharmacol; 1989 Apr; 27(4):519-22. PubMed ID: 2719906
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma.
Albani F; Riva R; Contin M; Baruzzi A
Br J Clin Pharmacol; 1984 Aug; 18(2):244-6. PubMed ID: 6487464
[TBL] [Abstract][Full Text] [Related]
14. Altered beta-adrenergic sensitivity and protein binding to 1-propranolol in the elderly.
Tenero DM; Bottorff MB; Burlew BS; Williams JB; Lalonde RL
J Cardiovasc Pharmacol; 1990 Nov; 16(5):702-7. PubMed ID: 1703590
[TBL] [Abstract][Full Text] [Related]
15. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
Paradiso-Hardy FL; Walker SE; Bowles SK
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
[TBL] [Abstract][Full Text] [Related]
16. Propranolol disposition after acute myocardial infarction.
Paxton JW; Norris RM
Clin Pharmacol Ther; 1984 Sep; 36(3):337-42. PubMed ID: 6467793
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness.
Paxton JW; Briant RH
Br J Clin Pharmacol; 1984 Nov; 18(5):806-10. PubMed ID: 6508990
[TBL] [Abstract][Full Text] [Related]
18. Differences in stereoselective disposition of propranolol do not explain sensitivity differences between white and Chinese subjects: correlation between the clearance of (-)- and (+)-propranolol.
Zhou HH; Wood AJ
Clin Pharmacol Ther; 1990 Jun; 47(6):719-23. PubMed ID: 2357866
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in propranolol pharmacokinetics.
Johnson JA; Burlew BS
Clin Pharmacol Ther; 1992 May; 51(5):495-500. PubMed ID: 1587062
[TBL] [Abstract][Full Text] [Related]
20. Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities.
Ward SA; Walle T; Walle UK; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1989 Jan; 45(1):72-9. PubMed ID: 2910639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
